Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.
about
Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistanceThe insulin receptor--a critical link in glucose homeostasis and insulin action.Metabolic and endocrine changes in persons aging with spinal cord injury.Obesity: fat cells--not fat people.Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects.Glucose transport and metabolism in adipocytes from newly diagnosed untreated insulin-dependent diabetics. Severely impaired basal and postinsulin binding activitiesInsulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes.Influence of obesity on the antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion.Insulin receptors in isolated human adipocytes. Characterization by photoaffinity labeling and evidence for internalization and cellular processing.Abnormal regulation of monocyte insulin-binding affinity after glucose ingestion in patients with myotonic dystrophy.Long-term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with and without non-insulin-dependent diabetes.Pathogenesis of selective insulin resistance in isolated hepatocytes.Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects.Increased insulin binding by hepatic plasma membranes from diabetic rats: normalization by insulin therapy.Evidence for insulin-induced internalization and degradation of insulin receptors in rat adipocytes.Visceral obesity: a "civilization syndrome".Hormonal control of inflammatory responses.Insulin signaling in type 2 diabetes: experimental and modeling analyses reveal mechanisms of insulin resistance in human adipocytes.Insulin signalling mechanisms for triacylglycerol storage.Glucocorticoid-induced insulin resistance: the importance of postbinding events in the regulation of insulin binding, action, and degradation in freshly isolated and primary cultures of rat hepatocytesMechanisms of insulin resistance in agingStudies of liver insulin receptors in non-obese and obese human subjectsMechanism of the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity.Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defectsEffects of insulin incubation on insulin binding, glucose transport, and insulin degradation by isolated rat adipocytes. Evidence for hormone-induced desensitization at the receptor and postreceptor level.Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding.Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents.Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia.MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels.Short-term overeating induces insulin resistance in fat cells in lean human subjects.Insulin resistance, energy balance and sympathetic nervous system activity.Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis.Age-dependent development of insulin resistance of soleus muscle in genetically obese (ob/ob) mice.Insulin binding and effects in isolated soleus muscle of lean and obese mice.Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation.Cross-talks via mTORC2 can explain enhanced activation in response to insulin in diabetic patients.Insulin receptor- and nonreceptor-controlled cellular substrate processing. A review of clinical studies in the isolated human adipocyte model.125I-8-L-arginine vasopressin binding to human mononuclear phagocytes.
P2860
Q33588931-8F28C380-51DE-437F-86B7-7962630D399AQ33599394-98331139-CD0B-4F0F-B102-12038EA76452Q34048371-AA859861-A9E1-412B-A138-ADC63A1CAEABQ34052268-2EFA7146-052F-407F-A800-7B5C769E0C1CQ34224154-E061B2EE-21FA-4DB0-BFF1-8B473E410BBAQ34556125-811B72D1-CD9C-401C-9310-E6D1D8DB7E3CQ34567954-E6F2B6BD-B971-4835-B567-C1B060AEE3C9Q34570368-DE2361BA-E90E-4897-B69D-83D860AB4DC1Q34605100-05CADFCB-3997-43A6-A7B3-D96BEAFA81A6Q35208007-A1340E3B-BE2C-4EDD-BF23-DCA0F0A03FA7Q35354294-4D02DF14-4B37-4E14-A0D9-BC8807150248Q35580223-775CDDA9-5B58-4002-94A4-06C104CBDA7FQ35662330-2BAAB627-B51B-48F4-A93E-F1018811CF3EQ35905345-7B43C6A4-83B3-4561-B9D4-3756E38DEE4CQ35905428-C9CD75EE-A750-4896-959E-C4C344E232A1Q36277363-08220C80-D52B-467B-B125-F2DF3AB5B6E0Q36340263-301D8EC8-EBB6-46EE-BFAD-19E4144960CDQ36627089-E6B52D76-B2A4-4C47-BCF0-9D5E2D2EAC2CQ36742249-8C8A704C-B262-476C-9296-E5BC88FDB99EQ36838847-75CCE6A0-31E2-4A04-BC25-E9E408A19A8BQ36982418-CA4CDE95-2D59-497E-953E-AC9C59DCD24AQ36989263-758E3058-8040-40E9-A1AB-D647146DB89FQ36992449-C003365F-EFAD-4FEA-9077-80A4D31C863DQ37003949-E7194C1A-741C-40DD-865A-08EE8F3EAC32Q37004187-3616E0FF-B2BD-4ACE-A69A-51AA15444DEBQ37023008-A1CE82FB-104B-430E-A7BD-2C28BFBF0E25Q37027591-92B0A06D-427B-4A71-81EA-FBCF3EB97CE5Q37030221-1AB4648E-A00D-4545-BAF2-3553C19E1D3CQ37041033-91E2ABDB-71E5-4649-AB1B-A33D2624B18FQ37054117-F86B2CF5-4C86-4BC2-9063-B8C872E1F0FFQ37237315-D77B0859-CEA1-45DA-8D4B-A8057C238636Q37254552-95989B7C-0B95-4926-B3C7-59407C9A8B8EQ37956640-BBDC9BFA-BD0D-400E-8EAC-14078F96CBE1Q38110890-2CD57424-52E5-4463-8321-29F872C2B3C3Q38356661-E2F7B49C-AD90-4BFD-9958-D1BE3CD94E0EQ38358272-59C5332F-9D42-4110-B9D5-CEA087822382Q38592281-AB5AC29F-4E44-4E83-9AAF-43D358004FF9Q38725775-413760CE-1F6C-4623-92B1-84D54958B00EQ39818422-474C413C-2C95-40AA-9A63-09D29C3709AAQ40683917-387CDF08-75B1-4558-9C75-FB70FA38C6FC
P2860
Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.
description
1976 nî lūn-bûn
@nan
1976 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.
@ast
Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.
@en
type
label
Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.
@ast
Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.
@en
prefLabel
Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.
@ast
Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.
@en
P2860
P356
P1476
Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.
@en
P2860
P304
P356
10.1172/JCI108384
P407
P577
1976-05-01T00:00:00Z